Evidence map›Paper›PMID 24835502›Full record

Trial reportThe Journal of allergy and clinical immunology2014

Eczema and race as combined determinants for differential response to step-up asthma therapy.

Jonathan Malka, David T Mauger, Ronina Covar, Nathan Rabinovitch, Robert F Lemanske, Joseph D Spahn, Robert C Strunk, Robert S Zeiger, Wayne J Morgan, Stanley J Szefler

Abstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Questions in Mild Asthma: An Official American Thoracic Society Research Statement.American journal of respiratory and critical care medicine · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. History of eczema is associated with more severe hospital course in children hospitalized for asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2018
    Article
  10. Trends in allergy prevalence among children aged 0-17 years by asthma status, United States, 2001-2013.The Journal of asthma : official journal of the Association for the Care of Asthma · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jonathan MalkaDepartment of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo; Pediatric Associates, Lauderdale Lakes, Fla.
David T MaugerDepartment of Health Evaluation Sciences, Pennsylvania State University, Hershey, Pa.
Ronina CovarDepartment of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.
Nathan RabinovitchDepartment of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.
Robert F LemanskeUniversity of Wisconsin School of Medicine and Public Health, Madison, Wis.
Joseph D SpahnDepartment of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.
Robert C StrunkDivision of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Wash.
Robert S ZeigerDepartment of Allergy, Kaiser Permanente and the Department of Pediatrics, University of California-San Diego, San Diego, Calif.
Wayne J MorganArizona Respiratory Center, University of Arizona, Tucson, Ariz.
Stanley J SzeflerDepartment of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo. Electronic address: szeflers@njhealth.org.

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
YOGA FOR THE MANAGEMENT OF HIV-METABOLIC SYNDROMESM01RR000036 · NCRR · WASHINGTON UNIVERSITY · PI REEDS, DOMINIC N · 1985 to 2007
$25.4M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
ZOSUQUIDAR TRIHYDROCHLORIDE IN NEWLY DIAGNOSED AMLM01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI SONDEL, PAUL M · 1986 to 2007
$19.3M
PEDIATRIC ASTHMA NETWORK DATA COORDINATING CENTERU10HL064313 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MAUGER, DAVID T. · 1999 to 2008
$18.3M
CHILDHOOD ASTHMA: EARLY PREVENTION AND PHARMACOGENETICSU10HL064307 · NHLBI · UNIVERSITY OF ARIZONA · PI MARTINEZ, FERNANDO D · 1999 to 2008
$9.0M
EARLY INTERVENTION IN CHILDHOOD ASTHMAU10HL064288 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J. · 1999 to 2008
$6.7M
NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR001082NCRR NIH HHS M01 RR000036NCRR NIH HHS M01-RR00036NCRR NIH HHS M01 RR003186NCRR NIH HHS M01-RR03186NCRR NIH HHS UL1 RR024992NCRR NIH HHS UL1-RR024992NCRR NIH HHS UL1 RR025011NCRR NIH HHS UL1-RR025011NCRR NIH HHS UL1 RR025780NHLBI NIH HHS HL064287NHLBI NIH HHS HL064288NHLBI NIH HHS HL064295NHLBI NIH HHS HL064305NHLBI NIH HHS HL064307NHLBI NIH HHS HL064313NHLBI NIH HHS U10 HL064287NHLBI NIH HHS U10 HL064288NHLBI NIH HHS U10 HL064295NHLBI NIH HHS U10 HL064305NHLBI NIH HHS U10 HL064307NHLBI NIH HHS U10 HL064313NIAID NIH HHS T32 AI007635NIAID NIH HHS T32AI007635
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetatesAdolescentAlbuterolAndrostadienesAnti-Asthmatic AgentsAsthmaBlack or African AmericanChildCross-Over StudiesCyclopropanesDrug CombinationsDrug MonitoringEczemaFemaleFluticasoneFluticasone-Salmeterol Drug CombinationAcetatesAlbuterolAndrostadienesAnti-Asthmatic AgentsCyclopropanesDrug CombinationsFluticasoneFluticasone-Salmeterol Drug CombinationmontelukastQuinolinesSulfides

Identifiers

PMID24835502
PMCPMC4119870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.